← Leaderboards
Ali Ahmed
U.S. Dept/Vets Affairs Medical Center
$4,451,837
Attributed
$7,604,123
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,604,123 · 5
VA$0 · 3
By mechanism
R01$7,104,352 · 4
K23$499,771 · 1
I01$0 · 3
Top collaborators
- Qing Zeng16 shared
- Wen-Chih Wu11 shared
- Edward Y Zamrini4 shared
- Charles J Faselis3 shared
Most similar at U.S. Dept/Vets Affairs Medical Center
Same institution · by research overlap
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignCohortAmericanHospitalizationCostVeteransHeart FailurePharmaceutical PreparationsMachine LearningRecommendationLinkGuidelinesHigh RiskBlindedMortalityDeep LearningPublic HealthCharacteristicsRisk Prediction ModelUnited States Centers For Medicare And Medicaid ServicesFollow-UpEvidence BaseUnited States Department Of Veterans AffairsLeft Ventricular Ejection Fraction
Grant awards (30)
MWAS+ â A Novel Drug Repurposing Strategy for ADRD Prevention$626,355
R01 · FY2025 · AG
Improving Outcomes in Veterans with Heart Failure and Chronic Kidney Disease$0
I01 · FY2025 · VA · contact PI
Improving Outcomes in Veterans with Heart Failure and Chronic Kidney Disease$0
I01 · FY2025 · VA · contact PI
Improving Outcomes in Veterans with Heart Failure and Chronic Kidney Disease$0
I01 · FY2025 · VA · contact PI
Understanding CNS Stimulant Use and Safety in Veterans with TBI$0
I01 · FY2025 · VA
MWAS+ â A Novel Drug Repurposing Strategy for ADRD Prevention$691,614
R01 · FY2024 · AG
Magnesium supplement and vascular health: Machine learning from the longitudinal medical record$457,519
R01 · FY2024 · HL
Diversity Supplement$138,409
R01 · FY2024 · HL
Complementary and Integrative Health Approaches to Improve TBI Outcomes in Veterans$0
I01 · FY2024 · VA
Understanding CNS Stimulant Use and Safety in Veterans with TBI$0
I01 · FY2024 · VA
MWAS+ â A Novel Drug Repurposing Strategy for ADRD Prevention$707,646
R01 · FY2023 · AG
Magnesium supplement and vascular health: Machine learning from the longitudinal medical record$467,958
R01 · FY2023 · HL
Understanding CNS Stimulant Use and Safety in Veterans with TBI$0
I01 · FY2023 · VA
MWAS+ â A Novel Drug Repurposing Strategy for ADRD Prevention$764,056
R01 · FY2022 · AG
Magnesium supplement and vascular health: Machine learning from the longitudinal medical record$415,275
R01 · FY2022 · HL
Magnesium supplement and vascular health: Machine learning from the longitudinal medical record$459,597
R01 · FY2021 · HL
Improving Outcomes in Veterans with Heart Failure and Chronic Kidney Disease$0
I01 · FY2021 · VA · contact PI
Improving Outcomes in Veterans with Heart Failure and Chronic Kidney Disease$0
I01 · FY2020 · VA · contact PI
Improving Outcomes in Veterans with Heart Failure and Chronic Kidney Disease$0
I01 · FY2019 · VA · contact PI
Neurohormonal Blockade and Outcomes in Diastolic Heart Failure$402,689
R01 · FY2010 · HL · contact PI
Neurohormonal Blockade and Outcomes in Diastolic Heart Failure$512,787
R01 · FY2009 · HL · contact PI
Heart failure, chronic kidney disease, and renin-angiotensin system inhibition$317,881
R01 · FY2009 · HL · contact PI
Heart failure, chronic kidney disease, and renin-angiotensin system inhibition$184,843
R01 · FY2009 · HL · contact PI
Heart failure, chronic kidney disease, and renin-angiotensin system inhibition$317,881
R01 · FY2008 · HL · contact PI
Heart failure, chronic kidney disease, and renin-angiotensin system inhibition$317,881
R01 · FY2007 · HL · contact PI
Heart failure, chronic kidney disease, and renin-angiotensin system inhibition$321,961
R01 · FY2006 · HL · contact PI
Heart Failure and Beta-Blocker Use in Older Adults$125,496
K23 · FY2006 · AG · contact PI
Heart Failure and Beta-Blocker Use in Older Adults$125,496
K23 · FY2005 · AG
Heart Failure and Beta-Blocker Use in Older Adults$125,496
K23 · FY2004 · AG
Heart Failure and Beta-Blocker Use in Older Adults$123,283
K23 · FY2003 · AG